Deutsche Bank Downgrades Xenon Pharmaceuticals (XENE) to Hold

September 18, 2026 3:42 AM

Deutsche Bank analyst David Hoang downgraded Xenon Pharmaceuticals (NASDAQ: XENE) from Buy to Hold with a price target of $46.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found